First Time Loading...

Biogaia AB
OTC:BGAIF

Watchlist Manager
Biogaia AB Logo
Biogaia AB
OTC:BGAIF
Watchlist
Price: 10.04 USD
Updated: May 6, 2024
Section:
 

Relative Value

BGAIF price has not been updated for more than 8 months. This may indicate that the stock has been delisted.

The Relative Value of one BGAIF stock under the Base Case scenario is 2.2 USD. Compared to the current market price of 10.04 USD, Biogaia AB is Overvalued by 78%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BGAIF Relative Value
Base Case
2.2 USD
Overvaluation 78%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.8
P/S
P/S
Price to Sales
8.8
vs History
33
vs Industry
50
Median 3Y
9
Median 5Y
8
Industry
8.3
Forward
8.1
More Details
31.3
P/E
P/E
Price to Earnings
31.3
vs History
31
vs Industry
6
Median 3Y
31.8
Median 5Y
24.2
Industry
26.8
Forward
28.4
More Details
26.9
P/OCF
P/OCF
Price to OCF
26.9
vs History
42
vs Industry
6
Median 3Y
30.9
Median 5Y
26.7
Industry
23.3
More Details
31.2
P/FCFE
P/FCFE
Price to FCFE
31.2
vs History
41
vs Industry
5
Median 3Y
34.2
Median 5Y
29
Industry
21.4
More Details
5.6
P/B
P/B
Price to Book Value
5.6
vs History
11
vs Industry
16
Median 3Y
5.2
Median 5Y
4.7
Industry
2.6
More Details
7.7
EV/S
EV/S
Enterprise Value to Sales
7.7
vs History
31
vs Industry
44
Median 3Y
7.9
Median 5Y
6.8
Industry
7.5
Forward
7
More Details
10.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.5
vs History
33
vs Industry
40
Median 3Y
10.8
Median 5Y
9.3
Industry
9.2
More Details
21.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.2
vs History
34
vs Industry
6
Median 3Y
22.1
Median 5Y
19
Industry
4.5
Forward
19.3
More Details
22.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.4
vs History
34
vs Industry
6
Median 3Y
23.4
Median 5Y
20.1
Industry
4.4
Forward
20.4
More Details
23.3
EV/OCF
EV/OCF
Enterprise Value to OCF
23.3
vs History
41
vs Industry
7
Median 3Y
26.4
Median 5Y
22.1
Industry
5.6
More Details
26.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26.3
vs History
39
vs Industry
6
Median 3Y
28
Median 5Y
24
Industry
3.4
More Details
12.6
EV/IC
EV/IC
Enterprise Value to IC
12.6
vs History
25
vs Industry
19
Median 3Y
12.2
Median 5Y
9.9
Industry
5
More Details

Multiples Across Competitors

BGAIF Competitors Multiples
Biogaia AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Biogaia AB
OTC:BGAIF
11.5B USD 8.8 31.3 21.2 22.4
US
Abbvie Inc
NYSE:ABBV
284.5B USD 5.2 59 12.8 19.6
US
Amgen Inc
NASDAQ:AMGN
160B USD 5.7 23.8 17.3 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.2B USD 7.9 26.4 17.7 19.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.7B USD 10.5 28.7 22.9 24
AU
CSL Ltd
ASX:CSL
133.1B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.5 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
45.9B USD 6.7 -9.7 -10.5 -8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.9B USD 3.3 27.3 14 17.5
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
BGAIF intrinsic value, competitors valuation, and company profile.
DCF Valuation
BGAIF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BGAIF stock valuation using valuation multiples.
Wall Street Estimates
BGAIF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BGAIF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.